Samuel Agresta
Net worth: 1 $ as of 30/01/2024
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Jacqualyn Fouse | M | 62 | 7 years | |
Ian Smith | M | 58 | 15 years | |
Kaye Foster-Cheek | F | 64 | 10 years | |
Richard Gaynor | M | 74 | 4 years | |
Scott Biller | M | 68 | 4 years | |
David Scadden | M | 71 | 7 years | |
Thomas Lynch | M | 63 | 2 years | |
May Kin Ho | M | 71 | 9 years | |
B. Parshall | F | 70 | 2 years | |
Jim Burns | M | 46 | 8 years | |
Michael LaCascia | M | 59 | 4 years | |
Carl C. Peck | M | - |
Georgetown University
| 30 years |
L. David de la Parte | M | - |
H. Lee Moffitt Cancer Center & Research Institute, Inc.
H. Lee Moffitt Cancer Center & Research Institute, Inc. Miscellaneous Commercial ServicesCommercial Services H. Lee Moffitt Cancer Center & Research Institute, Inc. provides research & contributions to clinical trials, prevention and cancer control. The firm operates as National Cancer Institute (NCI) Comprehensive Cancer Center. The company was founded by Lee H. Moffitt in 1981 and is headquartered in Tampa, FL. | 17 years |
Clive Patience | M | 60 | 7 years | |
Alfonso Quintás-Cardama | M | 53 | 1 years | |
Ellen Lopresti | F | - | 7 years | |
Saurabh Sewak | M | - | 2 years | |
Andrew Germain | M | - | 4 years | |
Mark Watson | M | 74 |
H. Lee Moffitt Cancer Center & Research Institute, Inc.
H. Lee Moffitt Cancer Center & Research Institute, Inc. Miscellaneous Commercial ServicesCommercial Services H. Lee Moffitt Cancer Center & Research Institute, Inc. provides research & contributions to clinical trials, prevention and cancer control. The firm operates as National Cancer Institute (NCI) Comprehensive Cancer Center. The company was founded by Lee H. Moffitt in 1981 and is headquartered in Tampa, FL. | 15 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Lawrence Bloch | M | 58 | 11 years | |
Kevin Starr | M | 61 | 7 years | |
Megan E. Pace | F | 51 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 5 years |
Constantine S. Potamianos | M | 58 |
Georgetown University
| 10 years |
Vani Chetty | F | 53 |
Georgetown University
| 9 years |
Pascal Soriot | M | 64 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | - |
Marc Tessier-Lavigne | M | 64 | 5 years | |
Jon S. Bouker | M | - |
Georgetown University
| 4 years |
Lewis Cantley | M | 75 | 10 years | |
Jeffrey Berkowitz | M | 58 | 6 years | |
Kane Brenan | M | - |
Georgetown University
| 4 years |
Glenn Goddard | M | 53 | 6 years | |
Robert Garnick | M | 74 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 24 years |
Derek M. Stoldt | M | - |
Georgetown University
| 8 years |
William McClements | M | 60 | 6 years | |
Alexandra Klopfer | F | - |
Georgetown University
| 5 years |
Steven Lo | M | 57 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 13 years |
Michael Porter | M | 76 | 8 years | |
Tom McCann Mullooly | M | - |
Georgetown University
| 7 years |
Steven Hoerter | M | 53 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 9 years |
Paul Clancy | M | 62 | 10 years | |
Ingrid Boyes | F | - |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 10 years |
Jeffrey A. Munsie | M | 47 | 8 years | |
Daniel O’Shea | M | - |
Georgetown University
| 18 years |
Dan Kamensky | M | - |
Georgetown University
| 7 years |
Asha Das | M | 59 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 7 years |
Holly Manning | F | - | 6 years | |
Andrew Laurino | M | 48 |
Georgetown University
| 4 years |
Darrin Miles | M | - | 6 years | |
Cigall Kadoch | M | 39 | 7 years | |
Nils Janson | M | - |
Georgetown University
| 5 years |
Josh Prentice | M | - |
Georgetown University
| 12 years |
Sandra Horning | M | 75 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | - |
Benjamin J. Strain | M | - | 2 years | |
José Baselga | M | 65 | 4 years | |
Michael Kauffman | M | 60 | 3 years | |
John M. Whiting | M | 69 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 20 years |
Perry Karsen | M | 69 | 5 years | |
Ian Clark | M | 62 | 6 years | |
Sujay Kango | M | 60 | 1 years | |
Stephanie Herseth Sandlin | F | 53 |
Georgetown University
| 4 years |
Stephen G. Juelsgaard | M | 75 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 24 years |
Robert Nelsen | M | 60 | 10 years | |
Michael C. Venuti | M | 70 | 17 years | |
Graig Suvannavejh | M | - |
Georgetown University
| 5 years |
Martin J. Waters | M | - |
Georgetown University
| 7 years |
Thomas O. Ix | M | - |
Georgetown University
| 8 years |
Philip Pallone | M | - |
Georgetown University
| 7 years |
Jacqueline Cinicola | F | - | 10 years | |
Dustin Smith | M | - |
Georgetown University
| 5 years |
Drew Shea | M | - |
Georgetown University
| 10 years |
David Lewis | M | - |
Georgetown University
| 4 years |
Justin G. Castillo | M | - |
Georgetown University
| 4 years |
Michael S. Steele | M | 65 |
Georgetown University
| 4 years |
Matthew Bigge | M | - |
Georgetown University
| 4 years |
Brian Hochheimer | M | - |
Georgetown University
| 3 years |
Brett Rogers | M | - |
Georgetown University
| 4 years |
Bryan Giraudo | M | 48 |
Georgetown University
| 4 years |
Thaddeus Gunn Coleman Strobach | M | - |
Georgetown University
| 4 years |
Paul Flick Strid | M | - |
Georgetown University
| 4 years |
Jeffrey R. Kovanda | M | - |
Georgetown University
| 4 years |
Brett Harold Krause | M | 55 |
Georgetown University
| 4 years |
Anna Kalathakis | F | 53 |
Georgetown University
| 4 years |
Shawn Lytle | M | 54 |
Georgetown University
| 4 years |
Camille Fleenor | F | - |
Georgetown University
| 1 years |
David Edward Rappa | M | 48 |
Georgetown University
| 4 years |
Igor Yermilin | M | - |
Georgetown University
| 4 years |
Craig S. Taylor | M | - |
Georgetown University
| 3 years |
Patrick Kelly | M | - |
Georgetown University
| 4 years |
Eugene Venanzi | M | 51 |
Georgetown University
| 4 years |
Bryan B. Arnold | M | - |
Georgetown University
| 3 years |
Mike P. Matthews | M | - |
Georgetown University
| 4 years |
David J. Aveni | M | - |
Georgetown University
| 4 years |
Felice C. Wagner | F | - |
Georgetown University
| 3 years |
Michael A. Lemp | M | - |
Georgetown University
| 9 years |
Deanne M. Ottaviano | F | - |
Georgetown University
| 3 years |
Maureen M. Roden | F | - |
Georgetown University
| 3 years |
Andrew B. Benett | M | 53 |
Georgetown University
| 4 years |
Thomas L. Robershaw | M | - |
Georgetown University
| 4 years |
Elizabeth M. Costa | F | - |
Georgetown University
| 4 years |
John M. Williams | M | - |
Georgetown University
| 3 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Samuel Agresta
- Personal Network